[Abstract #1575] Population Genetic Screening for Hereditary Breast and Ovarian Cancer in At-Risk Patients: A Novel Testing and Prevention Model for Community Hospitals Reveals High Mutation Rates Rurally

Presented at the American Society of Clinical Oncology 2020 (#ASCO20) Virtual Scientific Program, May 29 to May 31, 2020.

Authors

Charles H. Shelton¹, Theresa Smith¹, Leigh Boehmer², Christine B. Weldon³, William C. Guenther¹, Julia R. Trosman⁴, Antonio Ruiz⁵

¹Vidant Health, Nags Head, NC; ²Association of Community Cancer Centers, Rockville, MD; ³Northwestern University Feinberg School of Medicine, Chicago, IL; ⁴Center for Business Models in Healthcare, Chicago, IL; ⁵Chesapeake Regional Medical Center, Chesapeake, VA.

Genetic testing for at-risk non-cancer patients continues to increase.

We hypothesized rural areas could harbor higher than expected familial risks of breast and ovarian cancers due to demographic and social factors such as propinquity.

We created a model to 1) assess our population for familial cancer risk, 2) provide genetic counseling and testing, and 3) offer risk reduction strategies based on outcomes.